Skip to main content

PAVmed Inc.

PAVM
Exchange
Nasdaq
Industry
Surgical & Medical Instruments & Apparatus
SEC CIK
0001624326

No open-market purchases or sales by PAVmed Inc. insiders were filed in the last 90 days; 20 institutions reported holding it in 13F filings for Q2 2026, worth $5.56M in total; no superinvestor holds it.

Key figures

Market capClose on Nov 16, 2026
$14.0M
Insider buysOpen market, last 90 days
0
Insider sellsOpen market, last 90 days
0
13F holdersQ2 2026, 0 vs. previous quarter
20
13F valueReported value at the end of Q2 2026
$5.56M
Superinvestors holdingAt the end of Q2 2026
0

Price chart

From SEC filings, in USD.

Revenue, FY2025
$71.0K
−97.6% year over year
Net income, FY2025
$401.0K
−99.0% year over year
Free cash flow, FY2025
-$5.24M
No comparable prior period
Revenue, Q3 FY2026
$41.0K
+720.0% year over year

Short interest

See short data

From FINRA, settlement date Oct 30, 2026.

Short interest
12.8K
Shares sold short
Change
+95
+0.8% vs. previous
Days to cover
1.04
At average daily volume

Superinvestors holding PAVM, Q2 2026

Go to the superinvestors tab

No superinvestor reported holding PAVM at the end of Q2 2026.

Latest insider trades

See all insider trades

Open-market purchases and sales by PAVmed Inc. insiders from Form 4, newest first.

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Dec 7, 2022 (view filing)Dec 52 daysGlennon Michael JDirectorPPurchase+62.0K$0.69+$42.8KNew position62.0K after
Dec 7, 2022 (view filing)Dec 6-71 dayGlennon Michael JDirectorPPurchase+188.0K$0.6294+$118.3K+303.2%250.0K after2 lots

Top 10 13F holders, Q2 2026

See all 20 holders

The largest institutional positions in PAVmed Inc. at the end of Q2 2026; share changes are against Q1 2026.

Institutions holding PAVM in Q2 2026
InstitutionSharesValue% of portfolioChange in sharesAction
Two Seas Capital LP461,539$2.74M0.10%00.0%Unchanged
First Manhattan Co332,911$1.98M0.01%+309,106+1,298.5%Added
Vanguard Capital Management LLC61,604$365.9K0.00%+55,687+941.1%Added
Geode Capital Management, LLC36,678$217.9K0.00%+24,901+211.4%Added
Vanguard Fiduciary Trust Co25,605$152.1K0.00%+20,176+371.6%Added
BlackRock, Inc.17,092$101.5K0.00%+14,676+607.5%Added
Morgan Stanley163$9680.00%−2−1.2%Reduced
Barclays PLC75$4460.00%+75New
SBI Securities Co., Ltd.67$3980.00%00.0%Unchanged
UBS Group AG57$3390.00%−18−24.0%Reduced

Holders of 5% or more of PAVM

See all 9 holders and filings

Holders whose latest Schedule 13D or 13G filing reports 5% or more of PAVmed Inc..

Largest holders of PAVM from 13D and 13G filings
HolderLatest formStakeChangeFirst filedLatest filingFiling
Tasso Partners, LLC13G/A15.30%974.2K shares+1.00 ppfrom 14.30%Feb 28, 20253 filingsApr 14, 2026SEC
Ayrton Capital LLC13G/A9.99%709.1K shares+0.09 ppfrom 9.90%Feb 14, 20243 filingsMay 11, 2026SEC
Two Seas Capital LP13G9.99%657.2K sharesNewMay 15, 20261 filingMay 15, 2026SEC
Scopia Holdings LLC13G9.90%637.7K sharesNewApr 13, 20261 filingApr 13, 2026SEC
First Manhattan Co13G9.60%639.2K shares+5.30 ppfrom 4.30%Nov 14, 20243 filingsMay 14, 2026SEC